Biogen Idec, Inc. (BIIB) Misses Q1 EPS by 8c; Guides FY12
Tweet Send to a Friend
Get Alerts BIIB Hot Sheet
Price: $233.07 +0.75%
EPS Growth %: +40.7%
Financial Fact:
Selling, general and administrative: 375.98M
Today's EPS Names:
NED, OESX, WSTL, More
EPS Growth %: +40.7%
Financial Fact:
Selling, general and administrative: 375.98M
Today's EPS Names:
NED, OESX, WSTL, More
Trade BIIB Now!
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q1 EPS of $1.40, $0.08 worse than the analyst estimate of $1.48. Revenue for the quarter came in at $1.29 billion versus the consensus estimate of $1.31 billion.
Sees FY12 adj-EPS above $6.15, which compares to the Street estimate of $6.19.
Expecting to buyback an additional $500 million in common shares.
For earnings history and earnings-related data on Biogen Idec, Inc. (BIIB) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sees FY12 adj-EPS above $6.15, which compares to the Street estimate of $6.19.
Expecting to buyback an additional $500 million in common shares.
For earnings history and earnings-related data on Biogen Idec, Inc. (BIIB) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- UPDATE: 8x8 Inc. (EGHT) Misses Q4 EPS by 1c
- Target Corp. (TGT) Misses Q1 Views, Issues Mixed Outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Stock BuybacksRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
